Bluesky Facebook Reddit Email

Machine learning models predict hepatocellular carcinoma treatment response

08.17.22 | American Roentgen Ray Society

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.


Leesburg, VA, August 17, 2022 According to ARRS’ American Journal of Roentgenology ( AJR ) , machine learning models applied to presently underutilized imaging features could help construct more reliable criteria for organ allocation and liver transplant eligibility.

“The findings suggest that machine learning-based models can predict recurrence before therapy allocation in patients with early-stage hepatocellular carcinoma (HCC) initially eligible for liver transplant,” wrote corresponding author Julius Chapiro from the department of radiology and biomedical imaging at Yale University School of Medicine in New Haven, CT.

Chapiro and colleagues’ proof-of-concept study included 120 patients (88 men, 32 women; median age, 60 years) diagnosed with early-stage HCC between June 2005 and March 2018, who were initially eligible for liver transplant and underwent treatment by transplant, resection, or thermal ablation. Patients underwent pretreatment MRI and posttreatment imaging surveillance, and imaging features were extracted from postcontrast phases of pretreatment MRI examinations using a pretrained convolutional neural network (VGG-16). Pretreatment clinical characteristics (including laboratory data) and extracted imaging features were integrated to develop three ML models—clinical, imaging, combined—for recurrence prediction within 1–6 years posttreatment.

Ultimately, all three models predicted posttreatment recurrence for early-stage HCC from pretreatment clinical (AUC 0.60–0.78, across all six time frames), MRI (AUC 0.71–0.85), and both data combined (AUC 0.62–0.86). Using imaging data as the sole model input yielded higher predictive performance than clinical data alone; however, combining both data types did not significantly improve performance over use of imaging data alone.

An electronic supplement to this AJR article is available here .

North America’s first radiological society, the American Roentgen Ray Society (ARRS) remains dedicated to the advancement of medicine through the profession of medical imaging and its allied sciences. An international forum for progress in radiology since the discovery of the x-ray, ARRS maintains its mission of improving health through a community committed to advancing knowledge and skills with the world’s longest continuously published radiology journal— American Journal of Roentgenology —the ARRS Annual Meeting, InPractice magazine, topical symposia, myriad multimedia educational materials, as well as awarding scholarships via The Roentgen Fund ®.

MEDIA CONTACT :

Logan K. Young, PIO

44211 Slatestone Court

Leesburg, VA 20176

703-858-4332

lyoung@arrs.org

American Journal of Roentgenology

10.2214/AJR.22.28077

Observational study

Animals

Machine-Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study

17-Aug-2022

The authors declare no conflict of interest.

Keywords

Article Information

Contact Information

Logan Young
American Roentgen Ray Society
lyoung@arrs.org

Source

How to Cite This Article

APA:
American Roentgen Ray Society. (2022, August 17). Machine learning models predict hepatocellular carcinoma treatment response. Brightsurf News. https://www.brightsurf.com/news/19N49W01/machine-learning-models-predict-hepatocellular-carcinoma-treatment-response.html
MLA:
"Machine learning models predict hepatocellular carcinoma treatment response." Brightsurf News, Aug. 17 2022, https://www.brightsurf.com/news/19N49W01/machine-learning-models-predict-hepatocellular-carcinoma-treatment-response.html.